Zobrazeno 1 - 10
of 63
pro vyhledávání: '"R. P. Walt"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 1:23-30
Intragastric pH was measured continuously from 1800 to 1200 hours the following day in 22 duodenal ulcer patients and in eight gastric ulcer patients, all of whom had been admitted as emergencies with acute upper gastrointestinal haemorrhage. The eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf42c575894242952bc8f8237d0565c
https://doi.org/10.1111/j.1365-2036.1987.tb00602.x
https://doi.org/10.1111/j.1365-2036.1987.tb00602.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 9:483-490
SUMMARY Background: Helicobacter pylori eradication for peptic ulcer has been widely taken up. Evidence for the efficacy of different regimens is often derived from small series in clinical trials but there is little reporting of everyday practice wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642adffdacd8209973d71663ef6c706d
https://doi.org/10.1111/j.1365-2036.1995.tb00410.x
https://doi.org/10.1111/j.1365-2036.1995.tb00410.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 6:437-446
This three-way randomized crossover study in 18 healthy male volunteers compared the pharmacokinetics of 50 mg indomethacin b.d. during concomitant twice daily dosing with 400 micrograms misoprostol, 150 mg ranitidine or placebo. Plasma indomethacin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe2d6b3b1ecb527dedda84ac3c98b61b
https://doi.org/10.1111/j.1365-2036.1992.tb00557.x
https://doi.org/10.1111/j.1365-2036.1992.tb00557.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 6:373-380
SUMMARY Pantoprazole selectively blocks gastric parietal cell H+,K+-ATPase. To define a dosage regimen for clinical trials we compared the effect of pantoprazole 40 and 60 mg daily on 24-h intragastric acidity and plasma gastrin concentrations using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a13ea31dde8cb9506631b193601e3ba
https://doi.org/10.1111/j.1365-2036.1992.tb00058.x
https://doi.org/10.1111/j.1365-2036.1992.tb00058.x
Autor:
D. Kaufmann, M. Kempf, H S Merki, J. Röhmel, J Neumann, V. Müssig, L Witzel, R. P. Walt, E Scheurle
Publikováno v:
Alimentary Pharmacology & Therapeutics. 2:73-81
SUMMARY In a series of double-blind randomized studies in normal volunteers using continuous intragastric pH monitoring, the effects of different dosage regimens of roxatidine, a new H2-receptor antagonist, were compared with placebo and ranitidine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d656d1a48c0208d4085a2c6b604f0c0
https://doi.org/10.1111/j.1365-2036.1988.tb00674.x
https://doi.org/10.1111/j.1365-2036.1988.tb00674.x
Autor:
Roy E. Pounder, I. A. Santana, R. G. Long, R. F. A. Logan, R. P. Walt, K. W. Somerville, Michael J.S. Langman, Christopher J. Hawkey
Publikováno v:
Alimentary Pharmacology & Therapeutics. 1:161-166
The effects of bedtime 70 micrograms and twice daily 35 micrograms doses of enprostil on 24-hour intragastric acidity were investigated in nine duodenal ulcer patients in remission. Median nocturnal acidity decreased significantly by 30% with 35 micr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::513d2ba11acc5dfaefeca2290bbedcbf
https://doi.org/10.1111/j.1365-2036.1987.tb00615.x
https://doi.org/10.1111/j.1365-2036.1987.tb00615.x
Publikováno v:
Alimentary Pharmacology & Therapeutics. 10:749-755
Background : Low-dose H 2 -receptor antagonists are available without prescription for the self-medication of dyspepsia. Methods : To investigate the relative abilities of low doses of famotidine and ranitidine to raise intragastric pH after a single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327a6f32016a5944448756553182087e
https://doi.org/10.1046/j.1365-2036.1996.50192000.x
https://doi.org/10.1046/j.1365-2036.1996.50192000.x
Autor:
T. E. Bowling, R. N. Allan, M. J. G. Farthing, C. H. J. Swan, C. Farrell, C. Cobb, R. P. Walt, C. N. Mallinson, C. J. Tibbs, J. R. Bennett, W. R. Burnham, S. Catnach, Ian Gilmore, A. I. Morris, Christopher J. Hawkey, A. Towle
Publikováno v:
Gut. 38:459-470
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee498e83a0872fb83df8ea749b484163
https://doi.org/10.1136/gut.38.3.459
https://doi.org/10.1136/gut.38.3.459
Publikováno v:
Gut. 36:488-491
Between 1968 and 1991, the number of deaths from non-malignant oesophageal disease (NMOD) (International Classification of Diseases code 530), recorded by the Office of Population Censuses and Surveys (OPCS) in England and Wales, trebled in women, fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7004b19d8446e29cf7cfcc8bce9011ea
https://doi.org/10.1136/gut.36.4.488
https://doi.org/10.1136/gut.36.4.488
Autor:
R. P. Walt, T. G. Reilly
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 19:73-80
The treatment of duodenal ulcer has evolved from ineffective medical treatments through an era of surgical management, back to increasingly effective medical treatment. The advent of H2-receptor antagonists changed the outlook for ulcer patients. Mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4674a47ffca50cabac4ea6668fbc1626
https://doi.org/10.1111/j.1365-2710.1994.tb01115.x
https://doi.org/10.1111/j.1365-2710.1994.tb01115.x